Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports - 2Most loved Specially prepared Espresso Mix: Which Meal Do You Adore the Most?
- 3This Asian country is the next hot travel destination, and this is one of its best hotels
- 4Experiences in Natural life Protection: Individual Progressives' Excursions
- 5Brazilian cardinal orders a popular Catholic priest to go offline following right-wing attacks
- AbbVie plans to build out its presence in obesity market
- Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- What's the Fate of 5G Innovation?
- Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
- Don't miss the waxing moon swing by the Beehive star cluster March 27
- They died 'doing what they loved': The stories of workers in their 80s who died on the job
- IDF strikes Tehran command centers, weapon production sites
- The most effective method to Integrate Compact disc Rates into Your Retirement Arranging
- Gov’t approves millions for border cities in North under Hezbollah fire
